These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Bioresorbable Vascular Scaffolds for the Treatment of Chronic Total Occlusions: An International Multicenter Registry. Mitomo S; Naganuma T; Fujino Y; Kawamoto H; Basavarajaiah S; Pitt M; Yin WH; Tresukosol D; Colombo A; Nakamura S Circ Cardiovasc Interv; 2017 Jan; 10(1):. PubMed ID: 28069611 [TBL] [Abstract][Full Text] [Related]
11. Scaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold: A Systematic Review and Meta-Analysis. Lipinski MJ; Escarcega RO; Baker NC; Benn HA; Gaglia MA; Torguson R; Waksman R JACC Cardiovasc Interv; 2016 Jan; 9(1):12-24. PubMed ID: 26762906 [TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of first 300 implanted Absorb bioresorbable vascular scaffolds in an all-comers Middle East population. Al Nooryani A; Elabbassi WN; AlBaba B; Kerfes JA; Abudaqa LM; Bhatia A; Abdelrahman NA; Boskovic N; Beleslin B J Int Med Res; 2019 Jan; 47(1):173-187. PubMed ID: 30235969 [TBL] [Abstract][Full Text] [Related]
13. Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry. Capodanno D; Gori T; Nef H; Latib A; Mehilli J; Lesiak M; Caramanno G; Naber C; Di Mario C; Colombo A; Capranzano P; Wiebe J; Araszkiewicz A; Geraci S; Pyxaras S; Mattesini A; Naganuma T; Münzel T; Tamburino C EuroIntervention; 2015 Feb; 10(10):1144-53. PubMed ID: 25042421 [TBL] [Abstract][Full Text] [Related]
14. Comparison of early clinical outcomes between ABSORB bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world population. Costopoulos C; Latib A; Naganuma T; Miyazaki T; Sato K; Figini F; Sticchi A; Carlino M; Chieffo A; Montorfano M; Colombo A Catheter Cardiovasc Interv; 2015 Jan; 85(1):E10-5. PubMed ID: 24909303 [TBL] [Abstract][Full Text] [Related]
15. 1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials. Muramatsu T; Onuma Y; van Geuns RJ; Chevalier B; Patel TM; Seth A; Diletti R; García-García HM; Dorange CC; Veldhof S; Cheong WF; Ozaki Y; Whitbourn R; Bartorelli A; Stone GW; Abizaid A; Serruys PW; ; ; ; ; ; JACC Cardiovasc Interv; 2014 May; 7(5):482-93. PubMed ID: 24746650 [TBL] [Abstract][Full Text] [Related]
16. Clinical results of single and multiple bioresorbable drug-eluting scaffolds for treatment of de-novo coronary artery disease. Markovic S; Dragomir S; Walcher D; Bernhardt P; Imhof A; Rottbauer W; Wöhrle J Coron Artery Dis; 2016 Nov; 27(7):561-5. PubMed ID: 27244371 [TBL] [Abstract][Full Text] [Related]
17. Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trials. Campos CM; Caixeta A; Franken M; Bartorelli AL; Whitbourn RJ; Wu CJ; Li Paul Kao H; Rosli MA; Carrie D; De Bruyne B; Stone GW; Serruys PW; Abizaid A; Catheter Cardiovasc Interv; 2018 Feb; 91(3):387-395. PubMed ID: 28471086 [TBL] [Abstract][Full Text] [Related]
18. 1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries. Tamburino C; Capranzano P; Gori T; Latib A; Lesiak M; Nef H; Caramanno G; Naber C; Mehilli J; Di Mario C; Sabaté M; Münzel T; Colombo A; Araszkiewicz A; Wiebe J; Geraci S; Jensen C; Mattesini A; Brugaletta S; Capodanno D JACC Cardiovasc Interv; 2016 Mar; 9(5):440-9. PubMed ID: 26875648 [TBL] [Abstract][Full Text] [Related]
19. Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials. Muramatsu T; Onuma Y; García-García HM; Farooq V; Bourantas CV; Morel MA; Li X; Veldhof S; Bartorelli A; Whitbourn R; Abizaid A; Serruys PW; JACC Cardiovasc Interv; 2013 Mar; 6(3):247-57. PubMed ID: 23517836 [TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EU Registry. Capranzano P; Capodanno D; Brugaletta S; Latib A; Mehilli J; Nef H; Gori T; Lesiak M; Geraci S; Pyxaras S; Mattesini A; Münzel T; Araszkiewicz A; Caramanno G; Naber C; Di Mario C; Sabatè M; Colombo A; Wiebe J; Tamburino C Catheter Cardiovasc Interv; 2018 Feb; 91(3):444-453. PubMed ID: 29068130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]